Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06276647 · ClinicalTrials.gov registry record · NA
Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk
A NA study of Postpartum Depression and Maternal Behavior, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT06276647: Completed NA study of Postpartum Depression and Maternal Behavior, sponsored by University of Pennsylvania.
NCT06276647 is a NA study of Postpartum Depression and Maternal Behavior that has completed, run by University of Pennsylvania. The registered enrollment target is 220 participants, below the 471-participant average among 47 other Postpartum Depression trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06276647, a NA study of Postpartum Depression and Maternal Behavior, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this educational clinical trial is to identify high-need women most at risk for poor outcomes following delivery, the problems they experience, and to create a system to improve quality of postpartum care for these high-need patients. The main question\[s\] it aims to answer are: 1. How can the investigators help postpartum patients who have poor outcomes by decreasing the number of ED visits/readmissions for these patients within the first 30 days postpartum? 2. How can the investigators increase the ability of participants to "obtain needed services" and ability for patients to see their provider when they need to, in the 30-day post discharge period as one of the main pathways of unnecessary ED visits? Participants will be put into the study group or control group. The study group will receive a pamphlet postpartum with helpful information as well as a patient navigator who the participants will be able to reach out to their first 30 days postpartum.
Primary Outcome
To obtain data for the primary outcome of postpartum morbidity and mortality as measured by Emergency Department (ED) visits and hospital readmissions in the 30-day post discharge period. Investigators will use chart reviews to obtain this ED/Readmission information.
Conditions Studied
Interventions
- BEHAVIORAL HOME
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2024-02-20 |
| Est. Completion | 2025-12-05 |
| Phase | NA |
What the finished NCT06276647 record still lists
NCT06276647 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 471-participant average among 47 other Postpartum Depression trials with a reported enrollment target (53% lower).
The record links to 2 conditions, with Postpartum Depression appearing as the primary indexed condition, and to 1 intervention - of which HOME is the first listed.
NCT06276647 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06276647 about?
NCT06276647 is a clinical study titled "Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk". The goal of this educational clinical trial is to identify high-need women most at risk for poor outcomes following delivery, the problems they experience, and to create a system to improve quality of postpartum care for these high-need patients. The main question\[s\] it aims to answer are: 1. Ho...
What is the current status of trial NCT06276647?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2024-02-20. Estimated completion is 2025-12-05.
What conditions does trial NCT06276647 study?
This clinical trial studies the following conditions: Postpartum Depression, Maternal Behavior.
What interventions are being tested in trial NCT06276647?
The interventions under investigation include: HOME (BEHAVIORAL).
Who is sponsoring clinical trial NCT06276647?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06276647 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06276647's enrollment target sits among peer trials
220 17th of 47 higher than 31 of 47 other Postpartum Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
The Mom and Infant Outcomes (MOMI) Study
RECRUITING · NA
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI